製品の概要

製品の詳細

  • 由来Synthetic

関連製品

特性

Our Abpromise guarantee covers the use of ab48695 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    Blocking - Blocking peptide for Anti-ENT2 antibody (ab48595)

  • 製品の状態Liquid
  • 備考

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

関連情報

  • 別名
    • 36 kDa
    • 36 kDa nucleolar protein HNP36
    • Delayed-early response protein 12
    • DER12
    • ei-type
    • Equilibrative NBMPR-insensitive nucleoside transporter
    • Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter
    • Equilibrative nucleoside transporter 2
    • HNP36
    • Hydrophobic nucleolar protein
    • Hydrophobic nucleolar protein, 36 kDa
    • Nucleoside transporter
    • S29A2_HUMAN
    • SLC29A2
    • solute carrier family 29 (nucleoside transporters), member 29
    • Solute carrier family 29 member 2
    see all
  • 機能Mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine.
  • 組織特異性Expressed in skeletal muscle, liver, lung, placenta, brain, heart, kidney and ovarian tissues.
  • 配列類似性Belongs to the SLC29A/ENT transporter (TC 2.A.57) family.
  • 細胞内局在Basolateral cell membrane. Nucleus membrane. Localized at the basolateral cell membrane in polarized MDCK cells.
  • Information by UniProt

Human ENT2 peptide (ab48695) 使用論文

ab48695 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab48695.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"